These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15801949

  • 1. Scleromalacia perforans complicating graft-versus-host disease.
    Hon C, Law RW, Au WY.
    Br J Haematol; 2005 Apr; 129(1):1. PubMed ID: 15801949
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic stem cell transplantation from donors with mosaic Turner syndrome.
    Manola KN, Sambani C, Karakasis D, Baltathakis I, Zoumbos N, Symeonidis A.
    Bone Marrow Transplant; 2006 Sep; 38(5):385-6. PubMed ID: 16915227
    [No Abstract] [Full Text] [Related]

  • 3. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J, Serrano J, Gómez P, Martínez F, Martín C, Román-Gómez J, Rodríguez A, Herrera C, García JM, Alvarez MA, Torres A.
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [Abstract] [Full Text] [Related]

  • 4. Massive hematochezia secondary to graft-versus-host disease and cytomegalovirus.
    Shabahang M, Pasquale MD, Bitterman P, Cirenza E, Spitzer T, Evans SR.
    Am J Gastroenterol; 1994 Apr; 89(4):632-3. PubMed ID: 8147374
    [No Abstract] [Full Text] [Related]

  • 5. Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia.
    Perz JB, Khorashad JS, Marin D, Apperley JF, Olavarria E.
    Haematologica; 2006 Aug; 91(8):1145-6. PubMed ID: 16870551
    [Abstract] [Full Text] [Related]

  • 6. [Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation].
    Huang XJ, Jiang Q, Chen H, Xu LP, Liu DH, Chen YH, Han W, Zhang YC, Liu KY, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 27; 85(16):1097-101. PubMed ID: 16029565
    [Abstract] [Full Text] [Related]

  • 7. Chronic cutaneous graft-versus-host disease associated with multiple cutaneous squamous cell carcinomas.
    Brown SJ, Jackson GH, Reynolds NJ, Lawrence CM.
    Clin Exp Dermatol; 2006 May 27; 31(3):472-3. PubMed ID: 16681614
    [No Abstract] [Full Text] [Related]

  • 8. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
    Huff CA, Fuchs EJ, Smith BD, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH, Vogelsang GB, Griffin CA, Luznik L, Jones RJ.
    Biol Blood Marrow Transplant; 2006 Apr 27; 12(4):414-21. PubMed ID: 16545725
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
    Valcárcel D, Martino R, Piñana JL, Sierra J.
    Curr Opin Oncol; 2009 Jun 27; 21 Suppl 1():S35-7. PubMed ID: 19561412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Graft vs host disease].
    Moalic V, Ferec C.
    Pathol Biol (Paris); 2006 May 27; 54(5):304-8. PubMed ID: 16530350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genital graft-versus-host disease in a male following allogeneic stem cell transplantation.
    Nylander E, Wahlin YB, Lundskog B, Wahlin A.
    Acta Derm Venereol; 2007 May 27; 87(4):367-8. PubMed ID: 17598045
    [No Abstract] [Full Text] [Related]

  • 15. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
    Rowe JM.
    Best Pract Res Clin Haematol; 2008 Sep 27; 21(3):485-502. PubMed ID: 18790451
    [Abstract] [Full Text] [Related]

  • 16. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK.
    Clin Transplant; 2007 Sep 27; 21(2):207-13. PubMed ID: 17425746
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI.
    Biol Blood Marrow Transplant; 2006 Mar 27; 12(3):293-300. PubMed ID: 16503498
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
    Min CK, Kim SY, Lee MJ, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Kim CC, Cho CS.
    Bone Marrow Transplant; 2006 Jul 27; 38(2):149-56. PubMed ID: 16751784
    [Abstract] [Full Text] [Related]

  • 20. Epidermodysplasia verruciformis in the setting of graft-versus-host disease.
    Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S.
    J Am Acad Dermatol; 2007 Nov 27; 57(5 Suppl):S78-80. PubMed ID: 17938030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.